The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group
-
By
-
Martina Arcieri
-
Sandro Pignata
-
Domenica Lorusso
-
Anna Fagotti
-
Vito Chiantera
-
Antonino Ditto
-
Giorgio Valabrega
-
Claudia Marchetti
-
Claudio Zamagni
-
Valentina Tuninetti
-
Alberto Farolfi
-
Stefano Restaino
-
Giuseppe Vizzielli
-
May 28, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
MITO (Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies)
Milan, Lombardy
-
#2
The Ohio State University Comprehensive Cancer Center–James Cancer Hospital and Solove Research Institute
Columbus, Ohio
-
#3
Duke University School of Medicine
Durham, North Carolina
-
#4
Memorial Sloan Kettering Cancer Center
New York, New York
-
#5
IRCCS National Cancer Institute “Fondazione G. Pascale”
Naples, Campania
